Concepedia

Author

Samuli Eldfors

Institute for Molecular Medicine FinlandORCID

Also Known As

Eldfors, Samuli, S Eldfors, S. Eldfors, Samuli Eldfors

136

Publications

3.8K

Citations

24

H-Index

38

Concepts

All Affiliations

Institute for Molecular Medicine FinlandUniversity of HelsinkiHelsinki University HospitalUniversity of TurkuFinland University
SE

About

Samuli Eldfors is an author at Institute for Molecular Medicine Finland specializing in medicine, immunology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

440

2

Engineering

1

1

95

3

Health Sciences

1

1

14

4

Allergy

1

1

24

5

Biomolecular Engineering

1

1

95

Samuli Eldfors

×

31

Publications

3.4K

Citations

23

H-Index

YearCitations

Somatic <i>STAT3</i> Mutations in Large Granular Lymphocytic Leukemia

Hanna Koskela, Samuli Eldfors, Pekka Ellonen,

New England Journal of Medicine

2012

752

Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

Tea Pemovska, Mika Kontro, Bhagwan Yadav,

Cancer Discovery

2013

401

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

Hanna Rajala, Samuli Eldfors, Heikki Kuusanmäki,

Blood

2013

291

Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3

Emma Haapaniemi, Meri Kaustio, Hanna Rajala,

Blood

2014

273

Comparison of solution-based exome capture methods for next generation sequencing

Anna-Maija Sulonen, Pekka Ellonen, Henrikki Almusa,

Genome biology

2011

269

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

Disha Malani, Ashwini Kumar, Oscar Brück,

Cancer Discovery

2021

182

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Olli Dufva, Matti Kankainen, Tiina Kelkka,

Nature Communications

2018

139

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis

Paula Savola, Tiina Kelkka, Hanna Rajala,

Nature Communications

2017

118

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Heikki Kuusanmäki, Olli Dufva, Markus Vähä‐Koskela,

Blood

2022

112

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Emma Andersson, S. Pützer, Bhagwan Yadav,

Leukemia

2017

95

Page 1